Increased serum aldosterone in diabetic pregnancy

Area of Science:

• Endocrinology
• Reproductive Medicine
• Metabolic Disorders

Background:

• Gestational diabetes and Type 1 diabetes in pregnancy can impact maternal and fetal physiology.
• Hormonal regulation, including aldosterone and cortisol, plays a crucial role during pregnancy.

Purpose of the Study:

• To investigate serum levels of aldosterone and cortisol in pregnant women with gestational diabetes and Type 1 diabetes.
• To compare these levels with those in non-diabetic pregnant and non-pregnant control groups.
• To examine hormone levels in umbilical cord blood of infants born to diabetic and non-diabetic mothers.

Main Methods:

• Radioimmunoassay (RIA) was used to measure serum aldosterone and cortisol.
• Subjects included pregnant women with gestational diabetes (n=15), Type 1 diabetes (n=18), pregnant controls (n=36), and non-pregnant controls (n=10).
• Blood samples were collected in a supine position at 09:00 hours, with pregnant women sampled twice (weeks 32-34 and at delivery).

Main Results:

• Pregnant women with gestational diabetes and Type 1 diabetes exhibited consistently higher serum aldosterone levels compared to non-diabetic pregnant controls.
• Abnormal serum aldosterone levels were also detected in newborn infants of diabetic mothers.
• Serum cortisol levels did not show significant increases in diabetic pregnant women compared to controls.

Conclusions:

• Elevated maternal serum aldosterone is associated with both gestational diabetes and Type 1 diabetes during pregnancy.
• The observed abnormal aldosterone levels in newborns suggest potential transplacental effects or developmental alterations due to maternal diabetes.
• Cortisol levels do not appear to be similarly affected by diabetes in pregnancy in this study.